Pharmacovigilance Strategies Workshop

Session Chair(s)

Maarten Lagendijk, MSc

• Deputy EU QPPV
• MSD, Netherlands

James Whitehead, MSc

• Patient Safety Medical Device Lead
• Astrazeneca, United Kingdom

The digitalisation of the care pathway is accelerating and the past 24 months has only increased the pace of the digital health and medical devices revolution. We are seeing the influence of devices & digital on how patients are diagnosed, monitored and have their medicine administered. Everyone involved in patient care, from MAH’s and Regulators to Hospitals and Pharmacies, is challenged to keep up. This session will look at how digital health tools and medical devices are being used in clinical trials, how they could be utilised in the post-marketing space and how regulators have to work across boundaries—all of this with the goal of enhancing patient safety.

Speaker(s)

Use of Wearables to Monitor Patients – Case Studies

Emma Woods

• Astrazeneca, United Kingdom